1. Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis
   Zhi-Ping Jiang et al, 2017, Pharmacogenomics CrossRef
2. ABC-transporters and drug efflux in hematologic cancers
   Alberto Lazarowski, 2020, Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy CrossRef
3. Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH
   Jaurès B. Mettral et al, 2020, Drug Metabolism Letters CrossRef
4. MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: A meta-analysis
   N Louati et al, 2022, Journal of Oncology Pharmacy Practice CrossRef
5. Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors
   Claudia Neul et al, 2016, Trends in Pharmacological Sciences CrossRef
6. Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia
   Islem Ben Hassine et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef